A deep dive into the future of ophthalmology

This is the latest episode of the free DDW podcast, “A deep dive into the future of ophthalmology”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “Innovation, investment and commitment: Genentech’s approach to the future of ophthalmology” and “Innovative delivery of sustained ophthalmic steroids for high unmet needs in diabetic macular edema”.

Jeff Willis, MD, PhD is a Senior Medical Director and retina specialist at Genentech. In the first article, he talks to Lu Rahman about some of the company’s work developing medicine for eye disease and offers insight into the ophthalmology field today.

In the second article, Professor Sobha Sivaprasad, Professor of Retinal Clinical Studies, UCL Institute of Ophthalmology, and Consultant Ophthalmologist at Moorfields Eye Hospital, UK discusses unmet needs in DME therapeutics and how they could be addressed by sustained release ophthalmic steroids administered with novel suprachoroidal drug delivery methods.

You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Listen here:

Suggested Reading

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free